オピオイド誘発性便秘治療の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Opioid Induced Constipation Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-01643 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、オピオイド誘発性便秘治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。オピオイド誘発性便秘治療の種類別市場規模（経口、非経口（皮下注射））、用途別市場規模（ドラッグストア、個人薬局、病院薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GlaxoSmithKline、Takeda Pharmaceutical、S.L.A. Pharma、AstraZeneca、Salix Pharmaceuticals、Pfizer、Cubist Pharmaceuticals、AIKO Biotechnology ・地域別グローバル市場分析 2015年-2020年 ・オピオイド誘発性便秘治療の北米市場（アメリカ、カナダ、メキシコ） ・オピオイド誘発性便秘治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・オピオイド誘発性便秘治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・オピオイド誘発性便秘治療の南米市場（ブラジル、アルゼンチン） ・オピオイド誘発性便秘治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口、非経口（皮下注射） ・用途別分析：ドラッグストア、個人薬局、病院薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Opioid Induced Constipation Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 16.9% in the forecast period of 2020 to 2025 and will expected to reach USD 1888.6 million by 2025, from USD 1010.3 million in 2019.

The Opioid Induced Constipation Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Opioid Induced Constipation Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Opioid Induced Constipation Treatment market has been segmented into:
Oral
Parenteral (Subcutaneous Injection)

By Application, Opioid Induced Constipation Treatment has been segmented into:
Drug Store
Independent Pharmacies
Hospital Pharmacies

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Opioid Induced Constipation Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Opioid Induced Constipation Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Opioid Induced Constipation Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Opioid Induced Constipation Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Opioid Induced Constipation Treatment Market Share Analysis
Opioid Induced Constipation Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Opioid Induced Constipation Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Opioid Induced Constipation Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Opioid Induced Constipation Treatment are:
GlaxoSmithKline
Takeda Pharmaceutical
S.L.A. Pharma
AstraZeneca
Salix Pharmaceuticals
Pfizer
Cubist Pharmaceuticals
AIKO Biotechnology

レポート目次

---

Table of Contents

1 Opioid Induced Constipation Treatment Market Overview
1.1 Product Overview and Scope of Opioid Induced Constipation Treatment
1.2 Classification of Opioid Induced Constipation Treatment by Type
1.2.1 Global Opioid Induced Constipation Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Opioid Induced Constipation Treatment Revenue Market Share by Type in 2019
1.2.3 Oral
1.2.4 Parenteral (Subcutaneous Injection)
1.3 Global Opioid Induced Constipation Treatment Market by Application
1.3.1 Overview: Global Opioid Induced Constipation Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Drug Store
1.3.3 Independent Pharmacies
1.3.4 Hospital Pharmacies
1.4 Global Opioid Induced Constipation Treatment Market by Regions
1.4.1 Global Opioid Induced Constipation Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Opioid Induced Constipation Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Opioid Induced Constipation Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Opioid Induced Constipation Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Opioid Induced Constipation Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Opioid Induced Constipation Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Opioid Induced Constipation Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Takeda Pharmaceutical
2.2.1 Takeda Pharmaceutical Details
2.2.2 Takeda Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Takeda Pharmaceutical SWOT Analysis
2.2.4 Takeda Pharmaceutical Product and Services
2.2.5 Takeda Pharmaceutical Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 S.L.A. Pharma
2.3.1 S.L.A. Pharma Details
2.3.2 S.L.A. Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 S.L.A. Pharma SWOT Analysis
2.3.4 S.L.A. Pharma Product and Services
2.3.5 S.L.A. Pharma Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AstraZeneca SWOT Analysis
2.4.4 AstraZeneca Product and Services
2.4.5 AstraZeneca Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Salix Pharmaceuticals
2.5.1 Salix Pharmaceuticals Details
2.5.2 Salix Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Salix Pharmaceuticals SWOT Analysis
2.5.4 Salix Pharmaceuticals Product and Services
2.5.5 Salix Pharmaceuticals Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cubist Pharmaceuticals
2.7.1 Cubist Pharmaceuticals Details
2.7.2 Cubist Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Cubist Pharmaceuticals SWOT Analysis
2.7.4 Cubist Pharmaceuticals Product and Services
2.7.5 Cubist Pharmaceuticals Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 AIKO Biotechnology
2.8.1 AIKO Biotechnology Details
2.8.2 AIKO Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AIKO Biotechnology SWOT Analysis
2.8.4 AIKO Biotechnology Product and Services
2.8.5 AIKO Biotechnology Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Opioid Induced Constipation Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Opioid Induced Constipation Treatment Players Market Share
3.2.2 Top 10 Opioid Induced Constipation Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Opioid Induced Constipation Treatment Revenue and Market Share by Regions
4.2 North America Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
5 North America Opioid Induced Constipation Treatment Revenue by Countries
5.1 North America Opioid Induced Constipation Treatment Revenue by Countries (2015-2020)
5.2 USA Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
6 Europe Opioid Induced Constipation Treatment Revenue by Countries
6.1 Europe Opioid Induced Constipation Treatment Revenue by Countries (2015-2020)
6.2 Germany Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
6.4 France Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Opioid Induced Constipation Treatment Revenue by Countries
7.1 Asia-Pacific Opioid Induced Constipation Treatment Revenue by Countries (2015-2020)
7.2 China Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
7.5 India Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
8 South America Opioid Induced Constipation Treatment Revenue by Countries
8.1 South America Opioid Induced Constipation Treatment Revenue by Countries (2015-2020)
8.2 Brazil Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Opioid Induced Constipation Treatment by Countries
9.1 Middle East & Africa Opioid Induced Constipation Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Opioid Induced Constipation Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Opioid Induced Constipation Treatment Market Forecast by Type (2019-2024)
10.3 Oral Revenue Growth Rate (2015-2025)
10.4 Parenteral (Subcutaneous Injection) Revenue Growth Rate (2015-2025)
11 Global Opioid Induced Constipation Treatment Market Segment by Application
11.1 Global Opioid Induced Constipation Treatment Revenue Market Share by Application (2015-2020)
11.2 Opioid Induced Constipation Treatment Market Forecast by Application (2019-2024)
11.3 Drug Store Revenue Growth (2015-2020)
11.4 Independent Pharmacies Revenue Growth (2015-2020)
11.5 Hospital Pharmacies Revenue Growth (2015-2020)
12 Global Opioid Induced Constipation Treatment Market Size Forecast (2021-2025)
12.1 Global Opioid Induced Constipation Treatment Market Size Forecast (2021-2025)
12.2 Global Opioid Induced Constipation Treatment Market Forecast by Regions (2021-2025)
12.3 North America Opioid Induced Constipation Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Opioid Induced Constipation Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Opioid Induced Constipation Treatment Revenue Market Forecast (2021-2025)
12.6 South America Opioid Induced Constipation Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Opioid Induced Constipation Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Opioid Induced Constipation Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Opioid Induced Constipation Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Opioid Induced Constipation Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Opioid Induced Constipation Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GlaxoSmithKline Corporate Information, Location and Competitors
Table 6. GlaxoSmithKline Opioid Induced Constipation Treatment Major Business
Table 7. GlaxoSmithKline Opioid Induced Constipation Treatment Total Revenue (USD Million) (2017-2018)
Table 8. GlaxoSmithKline SWOT Analysis
Table 9. GlaxoSmithKline Opioid Induced Constipation Treatment Product and Solutions
Table 10. GlaxoSmithKline Opioid Induced Constipation Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Takeda Pharmaceutical Corporate Information, Location and Competitors
Table 12. Takeda Pharmaceutical Opioid Induced Constipation Treatment Major Business
Table 13. Takeda Pharmaceutical Opioid Induced Constipation Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Takeda Pharmaceutical SWOT Analysis
Table 15. Takeda Pharmaceutical Opioid Induced Constipation Treatment Product and Solutions
Table 16. Takeda Pharmaceutical Opioid Induced Constipation Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. S.L.A. Pharma Corporate Information, Location and Competitors
Table 18. S.L.A. Pharma Opioid Induced Constipation Treatment Major Business
Table 19. S.L.A. Pharma Opioid Induced Constipation Treatment Total Revenue (USD Million) (2017-2018)
Table 20. S.L.A. Pharma SWOT Analysis
Table 21. S.L.A. Pharma Opioid Induced Constipation Treatment Product and Solutions
Table 22. S.L.A. Pharma Opioid Induced Constipation Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. AstraZeneca Corporate Information, Location and Competitors
Table 24. AstraZeneca Opioid Induced Constipation Treatment Major Business
Table 25. AstraZeneca Opioid Induced Constipation Treatment Total Revenue (USD Million) (2017-2018)
Table 26. AstraZeneca SWOT Analysis
Table 27. AstraZeneca Opioid Induced Constipation Treatment Product and Solutions
Table 28. AstraZeneca Opioid Induced Constipation Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Salix Pharmaceuticals Corporate Information, Location and Competitors
Table 30. Salix Pharmaceuticals Opioid Induced Constipation Treatment Major Business
Table 31. Salix Pharmaceuticals Opioid Induced Constipation Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Salix Pharmaceuticals SWOT Analysis
Table 33. Salix Pharmaceuticals Opioid Induced Constipation Treatment Product and Solutions
Table 34. Salix Pharmaceuticals Opioid Induced Constipation Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Pfizer Corporate Information, Location and Competitors
Table 36. Pfizer Opioid Induced Constipation Treatment Major Business
Table 37. Pfizer Opioid Induced Constipation Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Pfizer SWOT Analysis
Table 39. Pfizer Opioid Induced Constipation Treatment Product and Solutions
Table 40. Pfizer Opioid Induced Constipation Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Cubist Pharmaceuticals Corporate Information, Location and Competitors
Table 42. Cubist Pharmaceuticals Opioid Induced Constipation Treatment Major Business
Table 43. Cubist Pharmaceuticals Opioid Induced Constipation Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Cubist Pharmaceuticals SWOT Analysis
Table 45. Cubist Pharmaceuticals Opioid Induced Constipation Treatment Product and Solutions
Table 46. Cubist Pharmaceuticals Opioid Induced Constipation Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. AIKO Biotechnology Corporate Information, Location and Competitors
Table 48. AIKO Biotechnology Opioid Induced Constipation Treatment Major Business
Table 49. AIKO Biotechnology Opioid Induced Constipation Treatment Total Revenue (USD Million) (2017-2018)
Table 50. AIKO Biotechnology SWOT Analysis
Table 51. AIKO Biotechnology Opioid Induced Constipation Treatment Product and Solutions
Table 52. AIKO Biotechnology Opioid Induced Constipation Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Opioid Induced Constipation Treatment Revenue (Million USD) by Players (2015-2020)
Table 54. Global Opioid Induced Constipation Treatment Revenue Share by Players (2015-2020)
Table 55. Global Opioid Induced Constipation Treatment Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Opioid Induced Constipation Treatment Revenue Market Share by Regions (2015-2020)
Table 57. North America Opioid Induced Constipation Treatment Revenue by Countries (2015-2020)
Table 58. North America Opioid Induced Constipation Treatment Revenue Market Share by Countries (2015-2020)
Table 59. Europe Opioid Induced Constipation Treatment Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Opioid Induced Constipation Treatment Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Opioid Induced Constipation Treatment Revenue by Countries (2015-2020)
Table 62. South America Opioid Induced Constipation Treatment Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Opioid Induced Constipation Treatment Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Opioid Induced Constipation Treatment Revenue Market Share by Countries (2015-2020)
Table 65. Global Opioid Induced Constipation Treatment Revenue (Million USD) by Type (2015-2020)
Table 66. Global Opioid Induced Constipation Treatment Revenue Share by Type (2015-2020)
Table 67. Global Opioid Induced Constipation Treatment Revenue Forecast by Type (2021-2025)
Table 68. Global Opioid Induced Constipation Treatment Revenue by Application (2015-2020)
Table 69. Global Opioid Induced Constipation Treatment Revenue Share by Application (2015-2020)
Table 70. Global Opioid Induced Constipation Treatment Revenue Forecast by Application (2021-2025)
Table 71. Global Opioid Induced Constipation Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Opioid Induced Constipation Treatment Picture
Figure 2. Global Opioid Induced Constipation Treatment Revenue Market Share by Type in 2019
Figure 3. Oral Picture
Figure 4. Parenteral (Subcutaneous Injection) Picture
Figure 5. Opioid Induced Constipation Treatment Revenue Market Share by Application in 2019
Figure 6. Drug Store Picture
Figure 7. Independent Pharmacies Picture
Figure 8. Hospital Pharmacies Picture
Figure 9. Global Opioid Induced Constipation Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Opioid Induced Constipation Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Opioid Induced Constipation Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Opioid Induced Constipation Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Opioid Induced Constipation Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Opioid Induced Constipation Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Opioid Induced Constipation Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Opioid Induced Constipation Treatment Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Opioid Induced Constipation Treatment Revenue Market Share in 2019
Figure 18. Global Top 10 Players Opioid Induced Constipation Treatment Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Opioid Induced Constipation Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Opioid Induced Constipation Treatment Revenue Market Share by Regions (2015-2020)
Figure 22. Global Opioid Induced Constipation Treatment Revenue Market Share by Regions in 2018
Figure 23. North America Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 24. Europe Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 26. South America Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 28. North America Opioid Induced Constipation Treatment Revenue Market Share by Countries (2015-2020)
Figure 29. North America Opioid Induced Constipation Treatment Revenue Market Share by Countries in 2019
Figure 30. USA Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Canada Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Europe Opioid Induced Constipation Treatment Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Opioid Induced Constipation Treatment Revenue Market Share by Countries in 2019
Figure 35. Germany Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 36. UK Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 37. France Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Russia Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Italy Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Opioid Induced Constipation Treatment Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Opioid Induced Constipation Treatment Revenue Market Share by Countries in 2019
Figure 42. China Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Japan Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Korea Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 45. India Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 47. South America Opioid Induced Constipation Treatment Revenue Market Share by Countries (2015-2020)
Figure 48. South America Opioid Induced Constipation Treatment Revenue Market Share by Countries in 2019
Figure 49. Brazil Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Opioid Induced Constipation Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Opioid Induced Constipation Treatment Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 54. UAE Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Opioid Induced Constipation Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Global Opioid Induced Constipation Treatment Revenue Share by Type (2015-2020)
Figure 58. Global Opioid Induced Constipation Treatment Revenue Share by Type in 2019
Figure 59. Global Opioid Induced Constipation Treatment Market Share Forecast by Type (2021-2025)
Figure 60. Global Oral Revenue Growth Rate (2015-2020)
Figure 61. Global Parenteral (Subcutaneous Injection) Revenue Growth Rate (2015-2020)
Figure 62. Global Opioid Induced Constipation Treatment Revenue Share by Application (2015-2020)
Figure 63. Global Opioid Induced Constipation Treatment Revenue Share by Application in 2019
Figure 64. Global Opioid Induced Constipation Treatment Market Share Forecast by Application (2021-2025)
Figure 65. Global Drug Store Revenue Growth Rate (2015-2020)
Figure 66. Global Independent Pharmacies Revenue Growth Rate (2015-2020)
Figure 67. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 68. Global Opioid Induced Constipation Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Opioid Induced Constipation Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Opioid Induced Constipation Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Opioid Induced Constipation Treatment Revenue Market Forecast (2021-2025)
Figure 72. Europe Opioid Induced Constipation Treatment Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Opioid Induced Constipation Treatment Revenue Market Forecast (2021-2025)
Figure 74. South America Opioid Induced Constipation Treatment Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Opioid Induced Constipation Treatment Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---